Market Access Strategy & Payer Relationships Dominate Average Budget Allocation Among Top 10 & Top 50 Pharma Companies
April 26, 2017 08:30 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - April 26, 2017) - Surveyed Top 50 companies spend $1.07 million on average for both market access strategy and payer relationships, according to a recent...
Half of Pharma Global Teams' Pharmacovigilance Funding is Contributed by a Standalone Drug Safety Team
April 25, 2017 07:30 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - April 25, 2017) - On average, half (50%) of surveyed global teams' pharmacovigilance funding is contributed by a standalone drug safety team, according to...
How Pharma Companies Use Digital Marketing and Direct-to-Consumer Advertising During Phase 3
April 05, 2017 10:14 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - April 05, 2017) - In addition to using medical science liaisons (MSLs) to engage the medical research community, many surveyed pharmaceutical companies have...
Over 60% of Surveyed Pharma Companies Position High-Level Executives to Support KAM Groups
April 04, 2017 07:45 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - April 04, 2017) - The largest percentage of surveyed pharmaceutical key account management (KAM) teams report to a director, according to a recent...
At Top Global Pharma Companies, Market Access Activities Begin at Least 16 Months Prior to Launch
March 30, 2017 10:18 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - March 30, 2017) - Surveyed Top 10 and Top 50 global companies begin pharmaceutical market access activities on average at least 16 months ahead of product...
Implementing Risk-Based Approaches During Longer Clinical Trials Maximizes Financial Impact
March 29, 2017 18:54 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - March 29, 2017) - Life science firms look to risk-based monitoring (RBM) to reduce costs associated with clinical studies, according to a study by business...
Surveyed Top 50 Pharma and Biotech Companies Report Average Per-Patient Costs of $57,500 During Non-Adaptive Phase 1 Studies
March 27, 2017 19:28 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - March 27, 2017) - Surveyed pharmaceutical, biotech, and device companies expend up to $120,000 per patient during Phase 1 non-adaptive studies, according to...
Roughly 70% of Surveyed Life Science Firms Have Altered Medical Communication Operations Due to Digital Resources
February 28, 2017 07:50 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - February 28, 2017) - Roughly 70% of life science firms have altered their medical communications with patients in response to newer technologies, such as...
30% of Drug Companies Compensate HCPs Differently for International vs. Domestic Air Travel
February 22, 2017 07:48 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC and DURHAM, NC--(Marketwired - February 22, 2017) - A study published by Cutting Edge Information found that 89% of surveyed drug company executives did not distinguish...
FMV Budget is a Top Criterion Among Surveyed Companies When Evaluating IIT Proposals
February 21, 2017 08:36 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - February 21, 2017) - Nearly one-third of surveyed pharmaceutical companies look to fair-market value (FMV) budget as one their most important criteria for...